EcoDrugPlus

Ensembl ID : ENSODEG00000019828
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSODEG00000019782
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSODEG00000004028
Gene Symbol: -
Cross references: -
251 Possible Orthologues:

Ensembl ID : ENSODEG00000020137
Gene Symbol: -
Cross references: -
38 Possible Orthologues:

Ensembl ID : ENSODEG00000006648
Gene Symbol: -
Cross references: -
251 Possible Orthologues:

Ensembl ID : ENSODEG00000016127
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSODEG00000007445
Gene Symbol: -
Cross references: -
255 Possible Orthologues:

Ensembl ID : ENSODEG00000007746
Gene Symbol: -
Cross references: -
249 Possible Orthologues:

Ensembl ID : ENSODEG00000008586
Gene Symbol: -
Cross references: -
251 Possible Orthologues:

Ensembl ID : ENSODEG00000009348
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSODEG00000002725
Gene Symbol: -
Cross references: -
107 Possible Orthologues:

Ensembl ID : ENSODEG00000002715
Gene Symbol: -
Cross references: -
107 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).